Calendar Adaptive Biotechnologies Corporation

Equities

ADPT

US00650F1093

Market Closed - Nasdaq 04:00:00 2024-02-23 pm EST 5-day change 1st Jan Change
4.04 USD +4.12% Intraday chart for Adaptive Biotechnologies Corporation +4.94% -17.55%

Chart calendar Adaptive Biotechnologies Corporation

aa.oYpYIuc9-gz2PT9IbMsZx7nY-491kHdEctAeHmHu1TU.4LphdqNLqXiaXG8LKP5ekdGdl74E5BxzFbRLSim6g2OQ7C9qjFGUTpJkXA~baaf4766ea1f76f76159c31695b48f50

Upcoming events on Adaptive Biotechnologies Corporation

2024-04-30 Q1 2024 Earnings Release (Projected)
2024-07-30 Q2 2024 Earnings Release (Projected)
2024-11-11 Q3 2024 Earnings Release (Projected)
2025-02-17 Q4 2024 Earnings Release (Projected)

Past events on Adaptive Biotechnologies Corporation

2024-02-14 04:30 pm Q4 2023 Earnings Call
2024-02-13 Q4 2023 Earnings Release After hours
2024-01-09 04:30 pm JPMorgan Healthcare Conference
2023-12-12 12:00 pm American Society of Hematology Meeting - Abstract No - LBA-1
2023-12-11 09:00 pm American Society of Hematology Meeting - Abstract No - 5029
2023-12-11 09:00 pm American Society of Hematology Meeting - Abstract No - 4359
2023-12-11 09:00 pm American Society of Hematology Meeting - Abstract No - 4715
2023-12-11 09:00 pm American Society of Hematology Meeting - Abstract No - 4747
2023-12-11 09:00 pm American Society of Hematology Meeting - Abstract No - 4407
2023-12-11 09:00 pm American Society of Hematology Meeting - Abstract No - 4847
2023-12-11 08:15 pm American Society of Hematology Meeting - Abstract No - 1024
2023-12-11 07:45 pm American Society of Hematology Meeting - Abstract No - 1028
2023-12-11 09:00 pm American Society of Hematology Meeting - Abstract No - 4671
2023-12-11 02:45 pm American Society of Hematology Meeting - Abstract No - 738
2023-12-10 09:00 pm American Society of Hematology Meeting - Abstract No - 3257
2023-12-10 09:00 pm American Society of Hematology Meeting - Abstract No - 3777
2023-12-10 09:00 pm American Society of Hematology Meeting - Abstract No - 3380
2023-12-10 09:00 pm American Society of Hematology Meeting - Abstract No - 3385
2023-12-10 09:00 pm American Society of Hematology Meeting - Abstract No - 3036
2023-12-10 09:00 pm American Society of Hematology Meeting - Abstract No - 3389

Annual results

Fiscal PeriodDecember 2018 2019 2020 2021 2022 2023
Net sales
Million USD
Released
Forecast
Spread
55,7


85,1
82,6
3.01%
98,4
94,8
3.77%
154
153
0.69%
185
185
0.16%
170
173
-1.5%
EBITDA
Million USD
Released
Forecast
Spread
0,00


-57,5
-54,5
-5.41%
-120
-123
2.98%
-152
-160
5.29%
-122
-158
23.14%
-116
-120
3.05%
EBIT
Million USD
Released
Forecast
Spread
0,00


-78,4
-74,5
-5.23%
-153
-147
-4.09%
-209
-211
0.86%
-200
-202
0.96%
-227
-203
-11.79%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00


-68,6
-73,2
6.31%
-146
-142
-3.05%
-207
-208
0.36%
-200
-209
3.91%
-225
-204
-10.4%
Net income
Million USD
Released
Forecast
Spread
0,00


-69,6
-63,9
-8.9%
-146
-142
-3.19%
-207
-208
0.37%
-200
-209
4.42%
-225
-204
-10.36%
EPS
USD
Released
Forecast
Spread
0,00


-1,01
-0,53
-90.57%
-1,11
-1,08
-2.91%
-1,48
-1,49
0.8%
-1,40
-1,47
4.71%
-1,56
-1,41
-10.57%
Announcement Date29/03/1926/02/2024/02/2115/02/2214/02/2314/02/24

Quarterly results

Fiscal PeriodDecember 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD
Released
Forecast
Spread
39,5
36,6
7.74%
37,9
36,9
2.93%
38,6
37,7
2.41%
43,7
41,8
4.43%
47,8
48,0
-0.42%
55,2
54,6
1.17%
37,6
36,8
2.27%
48,9
44,9
9%
37,9
43,0
-11.74%
45,8
48,5
-5.53%

38,2


43,4


43,3


50,6

EBITDA
Million USD
Released
Forecast
Spread
-41,1
-50,4
18.6%
-44,9
-47,3
5.02%
-45,2
-47,1
4.21%
-33,1
-38,7
14.3%
-25,9
-39,2
34.04%
-19,6
-33,5
41.63%
-37,1
-37,2
0.14%
-24,8
-36,3
31.61%
-29,8
-28,3
-5.47%
-24,7
-24,2
-2.03%

-33,7


-29,1


-26,1


-28,8

EBIT
Million USD
Released
Forecast
Spread
-56,3
-59,4
5.22%
-61,6
-66,4
7.29%
-63,1
-62,7
-0.6%
-52,5
-59,0
11.07%
-45,4
-53,1
14.42%
-39,2
-45,4
13.78%
-57,2
-53,0
-7.88%
-47,8
-48,1
0.51%
-51,0
-48,1
-5.91%
-71,1
-47,3
-50.27%

-51,4


-47,3


-45,6


-46,0

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-56,0
-60,4
7.29%
-61,4
-59,1
-3.78%
-62,8
-62,4
-0.72%
-52,1
-59,5
12.51%
-45,3
-54,9
17.49%
-40,2
-50,6
20.6%
-57,7
-60,5
4.61%
-47,8
-49,9
4.15%
-50,3
-47,5
-5.89%
-69,5
-47,7
-45.65%

-51,4


-47,4


-46,2


-46,8

Net income
Million USD
Released
Forecast
Spread
-55,9
-60,9
8.24%
-61,4
-65,4
6%
-62,7
-61,8
-1.47%
-52,0
-58,7
11.34%
-45,3
-54,7
17.29%
-40,1
-49,4
18.76%
-57,7
-56,7
-1.79%
-47,8
-50,2
4.72%
-50,3
-48,5
-3.64%
-69,4
-47,7
-45.6%

-51,4


-47,4


-46,2


-46,8

EPS
USD
Released
Forecast
Spread
-0,40
-0,43
6.43%
-0,43
-0,45
4.44%
-0,44
-0,44
0.01%
-0,37
-0,42
11.84%
-0,32
-0,38
16.04%
-0,28
-0,34
18.51%
-0,40
-0,38
-4.29%
-0,33
-0,34
3.62%
-0,35
-0,34
-4.22%
-0,48
-0,33
-47.26%

-0,35


-0,33


-0,32


-0,32

Announcement Date03/11/2115/02/2204/05/2203/08/2203/11/2214/02/2303/05/2302/08/2309/11/2314/02/24----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Adaptive Biotechnologies Corporation - Nasdaq
  4. Calendar Adaptive Biotechnologies Corporation
+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019
Replicate our performance
fermer